Hospital Universitario Virgen De Las Nieves

The Hospital Universitario Virgen De Las Nieves in Granada is highly active in neoplasms and blood cancers, with studies focused on diseases such as breast cancer, ovarian cancer, lung cancer, prostate cancer, bladder cancer, multiple myeloma, and lymphomas. The research is largely aimed at improving treatment effectiveness, comparing new combinations, and supporting better disease control in both early and advanced settings.

• Testing new treatment approaches for advanced and early-stage breast cancer, including hormone receptor-positive and HER2-related disease
• Evaluating therapies for multiple myeloma, myelodysplastic syndromes, and other hematologic cancers
• Studying targeted and immunotherapy-based options for lung cancer, bladder cancer, and prostate cancer

Many of these trials explore whether newer oncology strategies can improve survival, reduce recurrence, or offer better options after standard treatment has already been used.

Research at this site also covers respiratory diseases, immune system diseases, and allergic conditions, including asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, eosinophilic granulomatosis with polyangiitis, and urticaria. The trials are designed to assess symptom control, long-term safety, and the effectiveness of targeted therapies in chronic inflammatory disease.

• Improving treatment for asthma, including eosinophilic and difficult-to-control forms
• Studying advanced care for COPD and progressive fibrosing interstitial lung disease
• Evaluating therapies for atopic dermatitis, hidradenitis suppurativa, and other immune-driven skin conditions

These studies aim to help people with long-term inflammatory disorders achieve better symptom relief and more durable disease control.

The site conducts clinical research in cardiovascular diseases, kidney disorders, and metabolic disease, including hypertension, heart failure, cardiomyopathy, spontaneous coronary artery dissection, chronic kidney disease, and type 2 diabetes. These trials often focus on whether new treatments can improve organ function, lower risk, or better manage complex chronic illness.

• Assessing therapies for heart failure, hypertrophic cardiomyopathy, and other cardiac conditions
• Studying treatment options for resistant hypertension and vascular complications
• Evaluating kidney-focused research in delayed graft function, focal segmental glomerulosclerosis, and Alport syndrome

This area reflects a strong interest in improving outcomes for patients with overlapping heart, kidney, and metabolic risks.

Clinical trials in nervous system diseases and mental disorders include research on epilepsy, Parkinson’s disease, Alzheimer’s disease, glioblastoma-related neurological disease, and major depressive disorder. The research also includes studies of chronic pain, with an emphasis on improving symptom relief and daily functioning.

• Testing new options for focal epilepsy and seizure control
• Exploring treatments for early Parkinson’s disease and Alzheimer’s disease
• Evaluating approaches for chronic low back pain and depression with anhedonia

At Hospital Universitario Virgen De Las Nieves, these studies are aimed at helping patients manage persistent neurological symptoms with more effective and better-tolerated care.

A substantial part of the research portfolio addresses bacterial infections, viral disease, HIV infection, and transplant-related complications. Trials include studies in sepsis, bacteremia, infective endocarditis, acute graft-versus-host disease, and transplant-associated complications, with the goal of improving infection control and post-transplant recovery.

• Evaluating better treatment strategies for septic shock and severe bloodstream infections
• Studying supportive care after kidney transplantation, liver transplantation, and stem cell transplantation
• Investigating prevention and treatment of graft-versus-host disease and related immune complications

These trials focus on safer infection management and improved outcomes for patients undergoing high-risk medical and surgical care.

The site also supports research in skin and connective tissue diseases and eye diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, actinic keratosis, corneal ulcers, and thyroid eye disease. These studies are designed to improve symptom control, tissue healing, and long-term safety of treatment.

• Testing new therapies for psoriasis and other chronic inflammatory skin conditions
• Evaluating treatments for corneal disease and severe ocular surface damage
• Studying reconstructive approaches for skin cancer and wound repair

The research in this field combines symptom management with efforts to improve recovery and quality of life for patients with chronic dermatologic and eye conditions.

As a major Interna department research center, the site includes studies in digestive system diseases, liver disease, and metabolic disorders, such as acute pancreatitis, hepatocellular carcinoma, and post-gastrectomy or pancreatic insufficiency-related care. The purpose is often to compare supportive treatments, improve recovery, or refine care for complex internal medicine patients.

• Assessing treatment strategies for acute pancreatitis and related complications
• Studying liver-directed and immunotherapy-based approaches for hepatocellular carcinoma
• Exploring care needs after major gastrointestinal surgery and in nutritional and metabolic disease

These investigations reflect broad internal medicine research that connects organ-specific disease care with overall patient stability and recovery.